By way of derogation from Article 2(2), counterparties may provide in their risk management procedures that no collateral is exchanged in relation to non-centrally cleared OTC derivative contracts entered into with CCPs provided:1

1. (a) such CCPs are recognised by the Bank of England pursuant to Article 25 of Regulation (EU) No 648/2012 or by recognition order pursuant to Section 290 of the Financial Services and Markets Act 2000; and1

2. (b) such contracts are in respect of an activity which is carried on for the purposes of, or in connection with, the services or activities specified in the CCP’s recognition by the Bank of England pursuant to Article 25 of Regulation (EU) No 648/2012 or the CCP’s recognition order pursuant to Section 290 of the Financial Services and Markets Act 2000.1

By way of derogation from Article 2(2), counterparties may provide in their risk management procedures that no collateral is exchanged in relation to non-centrally cleared OTC derivative contracts entered into with non-financial counterparties that do not meet the conditions of Article 10(1)(b) of Regulation (EU) No 648/2012, or with non-financial entities established in a third country that would not meet the conditions of Article 10(1)(b) of Regulation (EU) No 648/2012 if they were established in the United Kingdom.

1. (1)

   By way of derogation from Article 2(2), counterparties may provide in their risk management procedures that no collateral is collected from a counterparty where the amount due from the last collection of collateral is equal to or lower than the amount agreed by the counterparties ("minimum transfer amount").

   The minimum transfer amount shall not exceed EUR 500000 or the equivalent amount in another currency.

2. (2)

   Where counterparties agree on a minimum transfer amount, the amount of collateral due shall be calculated as the sum of:

   1. (a)

      the variation margin due from its last collection calculated in accordance with Article 10, including any excess collateral;

   2. (b)

      the initial margin due from its last collection calculated in accordance with Article 11, including any excess collateral.

3. (3)

   Where the amount of collateral due exceeds the minimum transfer amount agreed by the counterparties, the collecting counterparty shall collect the full amount of collateral due without deduction of the minimum transfer amount.

4. (4)

   Counterparties may agree on separate minimum transfer amounts for initial and variation margins, provided that the sum of those minimum transfer amounts is equal to or lower than EUR 500000 or the equivalent amount in another currency.

5. (5)

   Where counterparties agree on separate minimum transfer amounts in accordance with paragraph 4, the collecting counterparty shall collect the full amount of initial or variation margin due without any deduction of those minimum transfer amounts where the amount of initial or variation collateral due exceeds the minimum transfer amount.

Where a counterparty is domiciled in a third country, counterparties may calculate margins on the basis of a netting set that includes the following types of contracts:

1. (a)

   non-centrally cleared OTC derivatives subject to margin requirements under this Regulation;

2. (b)

   contracts that meet both of the following conditions:

   1. (i)

      they are identified as non-centrally cleared OTC derivatives by the regulatory regime applicable to the counterparty domiciled in the third country;

   2. (ii)

      they are subject to margin rules in the regulatory regime applicable to the counterparty domiciled in the third country.

By way of derogation from Article 2(2), counterparties may provide in their risk management procedures that initial margins are not collected with respect to:

1. (a)

   physically settled OTC derivative contracts that solely involve the exchange of two different currencies on a specific future date at a fixed rate agreed on the trade date of the contract covering the exchange ("foreign exchange forwards");

2. (b)

   physically settled OTC derivative contracts that solely involve an exchange of two different currencies on a specific date at a fixed rate that is agreed on the trade date of the contract covering the exchange, and a reverse exchange of the two currencies at a later date and at a fixed rate that is also agreed on the trade date of the contract covering the exchange ("foreign exchange swaps");

3. (c)

   the exchange of principal of non-centrally cleared OTC derivative contracts under which counterparties exchange solely the principal amount and any interest payments in one currency for the principal amount and any interest payments in another currency, at specified points in time according to a specified formula ("currency swap").

1. (1)

   By way of derogation from Article 2(2), counterparties may provide in their risk management procedures that initial margins are not collected for all new OTC derivative contracts entered into within a calendar year where one of the two counterparties has an aggregate month-end average notional amount of non-centrally cleared OTC derivatives for the months March, April and May of the preceding year of below EUR 8 billion.

   The aggregate month-end average notional amount referred to in the first subparagraph shall be calculated at the counterparty level or at the group level where the counterparty belongs to a group.

2. (2)

   Where a counterparty belongs to a group, the calculation of the group aggregate month-end average notional amount shall include all non-centrally cleared OTC derivative contracts of the group including all intragroup non-centrally cleared OTC derivatives contracts.

   For the purposes of the first subparagraph, OTC derivative contracts which are internal transactions shall only be taken into account once.

3. (3)

   UK UCITS and AIFs (as defined in regulation 3 of the Alternative Investment Fund Managers Regulation 2013) managed by AIFMs (as defined in regulation 4 of the Alternative Investment Fund Managers Regulation 2013) authorised or registered in accordance with the Alternative Investment Fund Managers Regulations 2013 shall be considered distinct entities and treated separately when applying the thresholds referred to in paragraph 1 where the following conditions are met:

   1. (a)

      the funds are distinct segregated pools of assets for the purposes of the fund's insolvency or bankruptcy;

   2. (b)

      the segregated pools of assets are not collateralised, guaranteed or otherwise financially supported by other investment funds or their managers.

1. (1)

   By way of derogation from Article 2(2), counterparties may provide in their risk management procedures that initial margin collected is reduced by an amount up to EUR 50 million in the case of points (a) and (b) of this paragraph or EUR 10 million in the case of point (c) where:

   1. (a)

      neither counterparty belongs to any group;

   2. (b)

      the counterparties are part of different groups;

   3. (c)

      both counterparties belong to the same group.

2. (2)

   Where a counterparty does not collect initial margins in accordance with paragraph 1(b), the risk management procedures referred to in Article 2(1) shall include provisions on monitoring, at group level, whether that threshold is exceeded and provisions for the retention of appropriate records of the group's exposures to each single counterparty in the same group.

3. (3)

   UK UCITS and AIFs (as defined in regulation 3 of the Alternative Investment Fund Managers Regulation 2013) managed by AIFMs (as defined in regulation 4 of the Alternative Investment Fund Managers Regulation 2013) authorised or registered in accordance with the Alternative Investment Fund Managers Regulations 2013 shall be considered distinct entities and treated separately when applying the thresholds referred to in paragraph 1 where the following conditions are met:

   1. (a)

      the funds are distinct segregated pools of assets for the purposes of the fund's insolvency or bankruptcy;

   2. (b)

      the segregated pools of assets are not collateralised, guaranteed or otherwise financially supported by other investment funds or their managers.

1. (1)

   By way of derogation from Article 2(2) and where the conditions set out in paragraph 2 of this Article are met, counterparties may, in their risk management procedures, provide the following in relation to OTC derivative contracts concluded in connection with covered bonds:

   1. (a)

      variation margin is not posted by the covered bond issuer or cover pool but is collected from its counterparty in cash and returned to its counterparty when due;

   2. (b)

      initial margin is not posted or collected.

2. (2)

   Paragraph 1 applies where all of the following conditions are met:

   1. (a)

      the OTC derivative contract is not terminated in case of resolution or insolvency of the covered bond issuer or cover pool;

   2. (b)

      the counterparty to the OTC derivative concluded with covered bond issuers or with cover pools for covered bonds ranks at least pari passu with the covered bond holders except where the counterparty to the OTC derivative concluded with covered bond issuers or with cover pools for covered bonds is the defaulting or the affected party, or waives the pari passu rank;

   3. (c)

      the OTC derivative contract is registered or recorded in the cover pool of the covered bond in accordance with national covered bond legislation;

   4. (d)

      the OTC derivative contract is used only to hedge the interest rate or currency mismatches of the cover pool in relation to the covered bond;

   5. (e)

      the netting set does not include OTC derivative contracts unrelated to the cover pool of the covered bond;

   6. (f)

      the covered bond to which the OTC derivative contract is associated meets the requirements of paragraphs (1), (2) and (3) of Article 129 of Regulation (EU) No 575/2013;

   7. (g)

      the cover pool of the covered bond to which the OTC derivative contract is associated is subject to a regulatory collateralisation requirement of at least 102 %.

1. (1)

   By way of derogation from Article 2(2) and where the conditions set out in paragraph 2 of this Article are met, counterparties may provide in their risk management procedures the following in connection with OTC derivatives contracts that are concluded by a securitisation special purpose entity in connection with a securitisation as defined in regulation 3(1) of the Securitisation Regulations 2024 (SI 2024/102)1 and meeting the conditions of Article 4(5) of Regulation (EU) No 648/2012, as amended by the Securitisation (Amendment) Regulations 2024 (SI 2024/705)1:

   1. (a)

      that variation margin is not posted by the securitisation special purpose entity but is collected from its counterparty in cash and returned to its counterparty when due;

   2. (b)

      that initial margin is not posted or collected.

2. (2)

   Paragraph 1 shall apply where all of the following conditions are met:

   1. (a)

      the counterparty to the OTC derivative concluded with the securitisation special purpose entity in connection with the securitisation ranks at least pari passu with the holders of the most senior securitisation note, provided that counterparty is neither the defaulting nor the affected party;

   2. (b)

      the securitisation special purpose entity for the securitisation to which the OTC derivatives contract is associated is subject to a level of credit enhancement of the most senior securitisation note of at least 2 % of the outstanding notes on an ongoing basis;

   3. (c)

      the netting set does not include OTC derivative contracts unrelated to the securitisation.

1. (1)

   By way of derogation from Article 2(2), counterparties established in the United Kingdom may provide in their risk management procedures that variation and initial margins are not required to be posted for non-centrally cleared OTC derivative contracts concluded with counterparties established in a third country for which any of the following apply:

   1. (a)

      the legal review referred to in Article 2(3) confirms that the netting agreement and, where used, the exchange of collateral agreement cannot be legally enforced with certainty at all times;

   2. (b)

      the legal review referred to in Article 19(6) confirms that the segregation requirements referred to in Article 19(3), (4) and (5) cannot be met.

   For the purposes of the first subparagraph, counterparties established in the United Kingdom shall collect margin on a gross basis.

2. (2)

   By way of derogation from Article 2(2), counterparties established in the United Kingdom may provide in their risk management procedures that variation and initial margins are not required to be posted or collected for contracts concluded with counterparties established in a third country where all of the following conditions apply:

   1. (a)

      points (a) and, where applicable, point (b) of paragraph 1 apply;

   2. (b)

      the legal reviews referred to in points (a) and (b) of paragraph 1 confirm that collecting collateral in accordance with this Regulation is not possible, even on a gross basis;

   3. (c)

      the ratio calculated in accordance with paragraph 3 is lower than 2,5 %.

3. (3)

   The ratio referred to in paragraph 2(c) shall be the result of dividing the amount resulting from point (a) of this paragraph with that resulting from point (b):

   1. (a)

      the sum of the notional amounts of any outstanding OTC derivative contracts of the group to which the counterparty belongs that were concluded after the entry into force of this Regulation and for which no margin has been collected from counterparties established in a third country for which point (b) of paragraph 2 applies;

   2. (b)

      the sum of the notional amounts of all outstanding OTC derivative contracts of the group to which the counterparty belongs, excluding OTC derivative contracts that are intragroup transactions.